Covington Capital Management Accelerate Diagnostics, Inc Transaction History

Covington Capital Management

  • $23.2 Billion
  • Q3 2022

A detailed history of Covington Capital Management transactions in Accelerate Diagnostics, Inc stock. As of the latest transaction made, Covington Capital Management holds 175 shares of AXDX stock, worth $192. This represents 0.0% of its overall portfolio holdings.

Number of Shares
175
Holding current value
$192
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$1.01 - $17.0 $176 - $2,975
175 New
175 $0

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $109M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Covington Capital Management Portfolio

Follow Covington Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covington Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Covington Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email